|
|
|
|
FMC402b
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases/40 cores, replacing FMC402a
|
|
| Microarray Panel: | Multiple organ carcinoma frozen tissue microarray, containing 20 cases of carcinoma (1 each of colon adenocarcinoma, esophagus squamous cell carcinoma, soft tissue giant cell tumor, kidney clear cell carcinoma, liver hepatocellular carcinoma, skin squamous cell carcinoma, testis seminoma, lung adenocarcinoma and lung squamous cell carcinoma, 2 stomach adenocarcinoma, 6 ovary adenocarcinoma, 3 breast invasive ductal carcinoma) and 20 normal tissue (stomach, duodenum, small intestine, colon, parotid gland, thyroid gland, pancreas, prostate, aorta, testis, greater omentum, breast, lymph node, skin, medulla oblongata, spleen, uterus, vagina, bladder and nerve), single core per case |
| Cores: | 40 |
|
| Cases: | 40 |
| Layout: | 8 cols × 5 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Tissues were snap frozen in liquid nitrogen immediately after excision and were embedded in OCT. The array sections are 5-8 µm in thickness, mounted on positively charged glass slides, and briefly fixed by cold acetone. |
*Tissue Microarray Slide Types:
- Unstained: unstained
frozen
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Aor - Aorta,
Bla - Bladder,
Bre - Breast,
Col - Colon,
Duo - Duodenum,
Eso - Esophagus,
Gre - Greater omentum,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Lym - Lymph node,
Med - Medulla oblongata,
Ner - Nerve,
Ova - Ovary,
Pan - Pancreas,
Par - Parotid gland,
Pro - Prostate,
Ski - Skin,
Sma - Small intestine,
Sof - Soft tissue,
Spl - Spleen,
Sto - Stomach,
Tes - Testis,
Thy - Thyroid gland,
Ute - Uterus,
Vag - Vagina
- Malignant tumor,
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
|
A1 |
1 |
M |
35 |
Stomach |
Normal stomach tissue |
– |
Normal |
|
A2 |
2 |
M |
39 |
Duodenum |
Normal duodenum tissue |
– |
Normal |
|
A3 |
3 |
M |
35 |
Small intestine |
Normal small intestine tissue |
– |
Normal |
|
A4 |
4 |
M |
35 |
Colon |
Normal colon tissue (sparse) |
– |
Normal |
|
A5 |
5 |
M |
35 |
Parotid gland |
Normal parotid gland tissue |
– |
Normal |
|
A6 |
6 |
M |
35 |
Thyroid gland |
Normal thyroid tissue |
– |
Normal |
|
A7 |
7 |
M |
35 |
Pancreas |
Normal pancreas tissue |
– |
Normal |
|
A8 |
8 |
M |
35 |
Prostate |
Normal prostate tissue |
– |
Normal |
|
B1 |
9 |
M |
32 |
Aorta |
Normal aorta and squamous epithelial tissuetissue (sparse) |
– |
Normal |
|
B2 |
10 |
M |
35 |
Testis |
Normal testis tissue |
– |
Normal |
|
B3 |
11 |
M |
35 |
Greater omentum |
Normal greater omentum tissue |
– |
Normal |
|
B4 |
12 |
F |
56 |
Breast |
Normal breast tissue |
– |
Normal |
|
B5 |
13 |
M |
35 |
Lymph node |
Normal lymph node tissue |
– |
Normal |
|
B6 |
14 |
M |
35 |
Skin |
Normal skin tissue |
– |
Normal |
|
B7 |
15 |
F |
32 |
Medulla oblongata |
Normal medulla oblongata tissue |
– |
Normal |
|
B8 |
16 |
M |
51 |
Spleen |
Normal spleen tissue |
– |
Normal |
|
C1 |
17 |
F |
46 |
Uterus |
Normal cervix tissue |
– |
Normal |
|
C2 |
18 |
F |
44 |
Vagina |
Normal vaginal wall tissue (fibrous tissue and blood vessel) |
– |
Normal |
|
C3 |
19 |
M |
25 |
Bladder |
Normal bladder tissue (smooth muscle) |
– |
Normal |
|
C4 |
20 |
M |
33 |
Nerve |
Normal peripheral nerve tissue |
– |
Normal |
|
C5 |
21 |
M |
69 |
Colon |
Adenocarcinoma |
3 |
Malignant |
|
C6 |
22 |
M |
51 |
Esophagus |
Squamous cell carcinoma |
1 |
Malignant |
|
C7 |
23 |
F |
61 |
Stomach |
Adenocarcinoma |
3 |
Malignant |
|
C8 |
24 |
M |
61 |
Stomach |
Adenocarcinoma |
3 |
Malignant |
|
D1 |
25 |
F |
48 |
Ovary |
Adenocarcinoma |
2 |
Malignant |
|
D2 |
26 |
F |
70 |
Ovary |
Adenocarcinoma |
2 |
Malignant |
|
D3 |
27 |
F |
39 |
Ovary |
Adenocarcinoma |
2 |
Malignant |
|
D4 |
28 |
F |
53 |
Ovary |
Adenocarcinoma |
2 |
Malignant |
|
D5 |
29 |
F |
61 |
Ovary |
Adenocarcinoma |
2 |
Malignant |
|
D6 |
30 |
F |
38 |
Soft tissue |
Giant cell tumor |
– |
Malignant |
|
D7 |
31 |
F |
56 |
Kidney |
Clear cell carcinoma |
1 |
Malignant |
|
D8 |
32 |
M |
57 |
Liver |
Hepatocellular carcinoma |
2 |
Malignant |
|
E1 |
33 |
F |
52 |
Ovary |
Adenocarcinoma |
2 |
Malignant |
|
E2 |
34 |
F |
39 |
Breast |
Invasive ductal carcinoma |
1 |
Malignant |
|
E3 |
35 |
F |
42 |
Breast |
Invasive ductal carcinoma |
1 |
Malignant |
|
E4 |
36 |
F |
42 |
Breast |
Invasive ductal carcinoma |
2 |
Malignant |
|
E5 |
37 |
M |
78 |
Skin |
Squamous cell carcinoma |
1 |
Malignant |
|
E6 |
38 |
M |
50 |
Testis |
Seminoma |
– |
Malignant |
|
E7 |
39 |
M |
51 |
Lung |
Adenocarcinoma |
3 |
Malignant |
|
E8 |
40 |
M |
60 |
Lung |
Squamous cell carcinoma |
1–2 |
Malignant |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|